Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research focused on COPD and Exacerbation, with related work in Regorafenib, Azithromycin, Copd exacerbation. Notable publications include 'Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial', 'Prevention and management of adverse events related to regorafenib', and 'Sensitization to <em>Aspergillus fumigatus</em> as a risk factor for bronchiectasis in COPD'.
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) model
P4 Multidimensional classification for severity of exacerbations of COPD: the COPD exacerbation BAT (baseline, acuity, and trigger) conceptual model
Multidimensional classification for severity of exacerbations of COPD: The COPD Exacerbation BAT (Baseline, Acuity, and Trigger) conceptual model
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial
Sensitization to <em>Aspergillus fumigatus</em> as a risk factor for bronchiectasis in COPD
Prevention and management of adverse events related to regorafenib